The GPHF-Minilab™ - Counterfeit Medicines and Associated Health Risks

The incidence of counterfeiting pharmaceutical products and the proliferation of substandard quality medicines has been well identified internationally and constitutes serious health hazards. Counterfeiting of pharmaceutical products can take all kinds of form, but the end result is, when administered to a patient, that the consequences range from prolonged suffering, complete treatment failure, increased toxicity and and even outright death as a result of any of the above. Subpotent counterfeit anti-infectives may be also a contributional factor to drug resistance proliferation, which is a major concern of public health in malaria, TB and AIDS endemic countries.